Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer. Cooperberg MR, Lin DW, Morgan TM, Chapin BF, et al. J Urol 2021 Nov 15:101097JU0000000000002341. doi: 10.1097/JU.0000000000002341.

Read + Share

Amedeo Smart

Independent Medical Education

Cooperberg MR, Lin DW, Morgan TM, Chapin BF, et al. Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer. J Urol 2021 Nov 15:101097JU0000000000002341. doi: 10.1097/JU.0000000000002341.
PMID: 34775795